FDA Hits Indoco on Quality Control, Responses to 1,500 Complaints

Drug Industry Daily
A A
The FDA cited an Indoco Remedies API facility in Goa, India, for serious quality failures and inadequate handling of complaints.

To View This Article:

Login

Subscribe To Drug Industry Daily